Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Κατάταξη σε μετοχές #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Τιμή μετοχής
$25.28
Τελευταίος συγχρονισμός: 2026-09-18
Κεφαλαιοποίηση
$1.01B
Αλλαγή (1 ημέρα)
-2.29%
Αλλαγή (1 έτος)
-37.84%
Χώρα
GB
Εμπόριο GSK plc (GSK)

Κατηγορία

Έσοδα για την GSK plc (GSK)
Έσοδα τον Jun 2026 TTM: $45.18B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της GSK plc, τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $45.18B. Το 2024, η εταιρεία είχε έσοδα $39.37B αύξηση σε σχέση με τα έσοδα του έτους 2023, τα οποία ήταν $38.61B. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την GSK plc από 2000 έως 2026
Έσοδα στο τέλος κάθε έτους
Έτος Έσοδα Αλλαγή
2026 (TTM) $45.18B 5.15%
2025 $42.97B 9.13%
2024 $39.37B 1.98%
2023 $38.61B 8.83%
2022 $35.48B 6.25%
2021 $33.39B 0.28%
2020 $33.30B -25.61%
2019 $44.76B 14.02%
2018 $39.26B -3.77%
2017 $40.79B 18.52%
2016 $34.42B -2.36%
2015 $35.25B -1.64%
2014 $35.84B -18.35%
2013 $43.90B 2.38%
2012 $42.87B 0.88%
2011 $42.50B -3.83%
2010 $44.19B -3.75%
2009 $45.91B 29.14%
2008 $35.55B -21.53%
2007 $45.31B -0.48%
2006 $45.53B 22.17%
2005 $37.27B -2.94%
2004 $38.40B 0.32%
2003 $38.27B 12.00%
2002 $34.17B 14.47%
2001 $29.85B 10.60%
2000 $26.99B 0.00%
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Έσοδα Διαφορά Εσόδων Χώρα
$79.67B 76.33%
US
$97.93B 116.76%
US
$64.39B 42.51%
US
$77.52B 71.58%
CH
$66.40B 46.97%
US